Optimind Pharma CorpCanadian Securities Exchange:OMND
- LAST PRICE0.0050
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots0.0100/ 402
- Open / Previous Close0.0050 / 0.0050
- Day Range
- 52 Week Range
- Volume110,000
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | OMND |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Optimind Pharma Corp | 548.9K | -0.5x | --- |
WPD Pharmaceuticals Inc | 579.9K | -4.0x | --- |
Mydecine Innovations Group Inc | 617.6K | 0.0x | --- |
Chitogenx Inc | 415.7K | -0.2x | --- |
Albert Labs International Corp | 372.1K | -0.1x | --- |
Many Bright Ideas Technologies Inc | 228.9K | -3.3x | --- |
Company Information
Optimind Pharma Corp. is a Canada-based emerging provider of psychedelic therapies for the masses. The Company helps people suffering from post-traumatic stress disorder (PTSD), anxiety, depression and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities. The Company also partnered with developers of psilocybin-associated treatments and products to further expand its treatment and program offerings. Its treatment programs are designed based on scientific research and specific modalities used in many different therapeutic practices. Each treatment program combines the use of psychedelic medicine with therapeutic processing and integration. It has two different types of treatments. Monotherapy and assisted therapy, all based on a Ketamine capsule. The effects are felt about 30 minutes after, and within two hours of taking the medicine, cognition is resorted to normal.
Contact Information
- Headquarters
- 77 King Street West - Suite 3000TORONTO, ON, Canada M5K 1G8
- Phone
- ---
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $548.9K |
|---|---|
Revenue (TTM) | $111.4K |
Shares Outstanding | 109.8M |
Optimind Pharma Corp does not pay a dividend. | |
Beta | --- |
EPS | $-0.01 |
Book Value | $0.00 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | 4.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -723.17% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
